Internal Medicine, Rheumatology · Memphis, TN
NPI
1164789533
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6401 Poplar Ave Ste 190
Memphis, TN, 38119
Phone (901) 888-8770
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
366 services
Medicare patients, 2024
218
Average age 70
Drug cost, 2024
$5.6M
4,070 prescriptions
Company payments, 2025
$43.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vaishnavi R Pulusani was code 99214 (office e&m - established), 160 times for 127 patients. In total Vaishnavi R Pulusani billed 366 services in 16 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 160 | 127 | $69.86 | $11K |
| 99214 Office E&M - Established | Facility | 136 | 113 | $69.36 | $9,433 |
| 99204 Office E&M - New | Office | 20 | 20 | $101.28 | $2,026 |
| 99204 Office E&M - New | Facility | 19 | 19 | $80.77 | $1,535 |
By year: 2022 $31K for 359 services; 2023 $39K for 585 services; 2024 $25K for 366 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 178 | 123 | $8.30 | $1,477 |
Medicare prescription drug claims, 2024
In 2024, the drug Vaishnavi R Pulusani prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 671 prescriptions and refills. In total Vaishnavi R Pulusani wrote 4,070 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 671 | 1,840 | 266 | $34K |
| Methotrexate Methotrexate Sodium | 499 | 908 | 138 | $11K |
| Prednisone Generic | 470 | 1,182 | 223 | $3,678 |
| Gabapentin Generic | 279 | 331 | 78 | $5,158 |
| Pregabalin Generic | 234 | 244 | 62 | $4,004 |
| Leflunomide Generic | 209 | 534 | 77 | $20K |
| Humira(Cf) Pen Adalimumab | 170 | 183 | 25 | $1.3M |
| Enbrel Sureclick Etanercept | 133 | 133 | 19 | $997K |
| Duloxetine Hcl Generic | 121 | 262 | 43 | $2,939 |
| Orencia Clickject Abatacept | 116 | 121 | 21 | $712K |
| Cyclobenzaprine Hcl Generic | 109 | 144 | 43 | $1,039 |
| Benlysta Belimumab | 106 | 106 | 16 | $522K |
| Allopurinol Generic | 99 | 265 | 34 | $857 |
| Sulfasalazine Dr Sulfasalazine | 82 | 142 | 28 | $2,542 |
| Rinvoq Upadacitinib | 66 | 68 | 11 | $454K |
Brand drugs: 930 claims; generic drugs: 3,140 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vaishnavi R Pulusani $43.25 ($43.25 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.